With basic research on human primary cells from metabolically well-characterized donors (benign/malign obese subjects, responders/non-responders to lifestyle intervention, etc.), our goal is the amelioration of diagnostic and therapeutical possibilities in the field of prediabetes, diabetes, and obesity. Discovering the underlying molecular mechanisms and/or related biomarkers with the “omics” technology will lead us to translational progress.